中药质量源于设计应用:工艺控制策略
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家中药标准化项目(ZYBZH-C-QIN-45);国家自然科学基金项目(81403112);国家自然科学基金重点项目(81430094)


Chinese Medicine Quality Derived From Design Methods and Applications for-(Ⅴ):Process Control Strategy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    在药品质量源于设计(Quality by Design,QbD)框架下,工艺控制策略是用于确保产品质量和工艺性能符合预期目标的一套计划性控制方法和步骤的组合。工艺控制策略的先进程度取决于对药品和制药工艺的理解和相关知识水平的积累。目前,国内制药工艺控制正经历从质量源于检验(QbT)模式向QbD模式的转变。本文总结并比较了分别由美国FDA的Lawrance Yu和国际制药工程协会PQLI工作组提出的工艺控制策略等级模型。介绍了药物产品质量实时放行测试、工艺设计空间、工艺前馈控制和反馈控制、工艺闭环控制、工艺智能控制等先进工艺控制方法和策略,及其在中药和药品生产中的应用。

    Abstract:

    Under the framework of pharmaceutical quality by design (QbD), a process control strategy is defined as a combination of a set of planning control methods and procedures used to ensure product quality and process performance which meets expected goals. The advanced process control strategy depends on the understanding of pharmaceutical processes and the accumulation of relevant knowledge. At present, the control of the domestic pharmaceutical process is experiencing a shift from the quality by testing (QbT) mode to the QbD mode. This paper summarizes and compares the hierarchy models of process control strategy proposed by Lawrance Yu of the U.S. FDA and the PQLI working group of the International Society of Pharmaceutical Engineering. Advanced process control methods, such as realtime release testing of drug product quality, process design space, feedforward control and feedback process control, closed-loopprocess control and intelligent process control, as well as their applications in Chinese medicine and pharmaceutical production were reviewed.

    参考文献
    相似文献
    引证文献
引用本文

连传运,徐冰,王秋平,于佳琦,史新元,乔延江.中药质量源于设计应用:工艺控制策略[J].世界中医药,2018,(03).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2017-12-13
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2018-04-04
  • 出版日期:
文章二维码